Alaunos Therapeutics Inc (TCRT) — Tangible Net Worth Ratio
Alaunos Therapeutics Inc (TCRT) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($652.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Alaunos Therapeutics Inc (TCRT) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Alaunos Therapeutics Inc Tangible Net Worth Ratio (2005–2025)
This chart shows how Alaunos Therapeutics Inc's Tangible Net Worth Ratio has changed across 19 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $652.00K with intangible assets of $0.00 USD. For live market cap and overall valuation, see Alaunos Therapeutics Inc (TCRT) total market value.
Annual Tangible Net Worth Ratio for Alaunos Therapeutics Inc (2005–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Alaunos Therapeutics Inc from 2005 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Alaunos Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $2.15 Million | $0.00 | $2.97 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $2.06 Million | $0.00 | $2.75 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $6.31 Million | $0.00 | $8.26 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $38.55 Million | $0.00 | $64.94 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $58.06 Million | $0.00 | $94.86 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $123.98 Million | $0.00 | $146.34 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $95.01 Million | $0.00 | $109.11 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $85.56 Million | $0.00 | $95.05 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $87.37 Million | $0.00 | $153.72 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $33.84 Million | $0.00 | $45.24 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $49.38 Million | $0.00 | $71.75 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $48.45 Million | $0.00 | $83.40 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $71.61 Million | $0.00 | $108.11 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $30.55 Million | $0.00 | $61.52 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $28.10 Million | $0.00 | $49.74 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $6.74 Million | $0.00 | $12.57 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $30.37 Million | $0.00 | $36.73 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $26.53 Million | $0.00 | $29.51 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $7.20 Million | $0.00 | $9.49 Million | — |